Study Stopped
The study staff has left the clinic.
Alteration of Blood-Brain-Barrier Permeability at Loss of Consciousness in Delirious Patients Recorded With Direct-Current Electroencephalography (ACDC)
1 other identifier
observational
24
1 country
1
Brief Summary
With this trial we aim to characterize the intraoperative signatures of the Direct-Current-Electroencephalogram (DC-EEG) of elderly patients developing a PostOperative Delirium (POD) compared to patients who do not develop a POD. We hereby intend to gain a better understanding of the electrical potential at the blood-brain-barrier (measured with DC-EEG) during general anaesthesia. Second, we want to study the effect of age on the DC-EEG by comparing a younger (18-30y) to an elderly cohort (\>70). Third, we aim to couple the DC-EEG signatures to blood sample analysis in order to understand the relationship between metabolic, inflammatory and vascular reaction with the intraoperative DC-EEG.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 23, 2020
CompletedFirst Posted
Study publicly available on registry
March 24, 2020
CompletedStudy Start
First participant enrolled
August 10, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 11, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 11, 2021
CompletedMay 7, 2025
May 1, 2025
1.3 years
March 23, 2020
May 5, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
1. DC-Shift (µV/sec) in the perioperative DC-EEG.
Full-brain DC-EEG with 21 electrodes placed preoperatively following the 10/20-System and recording until one hour after regain of consciousness.
From the beginning of general anaesthesia to one hour after regain of consciousness
Secondary Outcomes (9)
Incidence of Postoperative Delirium
Patients will be follow until hospital discharge, or maximal until postoperative day 5
Additional perioperative DC-EEG signatures: morphology, polarity (positive/negative), amplitude (µV)
From the beginning of general anaesthesia to one hour after regain of consciousness
DC-EEG signatures in young (18-30) vs. elderly (>70) patients
From the beginning of general anaesthesia to one hour after regain of consciousness
Analysis of pre-, intra- and postoperative blood parameters
: From shortly before the beginning of general anaesthesia to maximum one hour after arrival in the recovery room
Peri-operative, full-brain overall EEG band power
Up to the end of stay in the recovery room
- +4 more secondary outcomes
Study Arms (2)
Elderly cohort
Patients \>70 undergoing elective orthopaedic or trauma surgery under general anaesthesia.
Young cohort
Patients between 18 and 30 undergoing elective orthopaedic or trauma surgery under general anaesthesia.
Eligibility Criteria
Elderly Cohort: Patients \>70 undergoing elective orthopaedic or trauma surgery under general anaesthesia. Young cohort: Patients between 18 and 30 undergoing elective orthopaedic or trauma surgery under general anaesthesia.
You may qualify if:
- Patients aged \>70 years OR between 18 and 30
- Planned operation time \>1 hour
- Expected hospital treatment period of 5 days,
- Anesthesia induction, anesthesia maintenance with either Propofol or an inhalative anesthetic agent as Sevoflurane or Desflurane,
- The ability to give informed consent
You may not qualify if:
- Age under 18 or between 31 and 69
- Patients with a history of neurological or psychiatric disorders
- Planned neurosurgery
- Current medication of tranquilizers / antidepressants
- Isolation of patients with multi-resistant Bacteria
- Inability of the patients to speak and/or read German
- Intraoperative use of ketamine, N²O, Etomidate or Dexmedetomidine
- Participation in a prospective interventional trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Anesthesiology and Operative Intensive Care Medicine (CCM/CVK), Charité - Universitätsmedizin Berlin
Berlin, 13353, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Claudia Spies, MD, Prof.
Charite University, Berlin, Germany
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of the Department of Ansthesiology and Operative Intensive Care Medicine, Charité - Universitätsmedizin Berlin
Study Record Dates
First Submitted
March 23, 2020
First Posted
March 24, 2020
Study Start
August 10, 2020
Primary Completion
November 11, 2021
Study Completion
November 11, 2021
Last Updated
May 7, 2025
Record last verified: 2025-05